Expedeon has a patent portfolio covering several novel technologies:
Antibody (protein) labeling
Novel protein labeling technologies that drastically reduce the amount of labour required to make conjugates, permitting rapid and comprehensive optimisation with just micrograms of material, combined with freely scalable bulk production processes.
Assay technologies and reagents for measuring the activity of kinases, phosphatases, proteases and other enzymes of relevance to human health and drug discovery.
SunScript™ is a trademark of SYGNIS AG or one of its subsidiaries (SYGNIS BIOSCIENCE GmbH & Co. KG or SYGNIS BIOTECH, S.L.U.). All rights reserved.
SunScript™ One Step RT-qPCR Kit includes SunScript™ Reverse Transcriptase RNaseH+. Patent protection is pending for SunScript™ Reverse Transcriptase RNaseH+ and methods associated with its use.
SunScript™ One Step RT-qPCR Kit includes a non-transferable license to use SunScript™ Reverse Transcriptase RNaseH+ and the SunScript™ RT-qPCR kit for the purchaser’s internal research. All other commercial uses of this product, including without limitation product use for diagnostic purposes, resale of product in the original or any modified form or product use in providing commercial services require a separate license.
The purchase of this product includes a limited, non-transferable license for all fields other than human or veterinary in vitro diagnostics under specific claims of U.S. Patent Nos. 6,174,670 and 6,569,627, owned by the University of Utah Research Foundation and licensed to BioFire Defense, LLC and Roche Diagnostics GmbH, to use only the enclosed amount of product according to the specified protocols. No right is conveyed, expressly, by implication, or by estoppel, to use any instrument or system under any claim of U.S. Patent Nos. 6,174,670 and 6,569,627, other than for the amount of product contained herein.
SYBR is a registered trademark of Molecular Probes, Inc.
Further information on licensing opportunities may be obtained by contacting us.